4//SEC Filing
Huizenga Theodore Alan 4
Accession 0001209191-23-048905
CIK 0001515673other
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 1:52 PM ET
Size
10.5 KB
Accession
0001209191-23-048905
Insider Transaction Report
Form 4
Huizenga Theodore Alan
Controller and PAO
Transactions
- Sale
Common Stock
2023-09-07$38.34/sh−163$6,249→ 23,614 total - Exercise/Conversion
Common Stock
2023-09-07$21.00/sh+2,000$42,000→ 25,777 total - Sale
Common Stock
2023-09-07$41.00/sh−2,000$82,000→ 23,777 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-09-07−2,000→ 3,000 totalExercise: $21.00Exp: 2024-01-29→ Common Stock (2,000 underlying)
Footnotes (3)
- [F1]The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023.
- [F2]Includes previously reported shares of common stock underlying restricted stock units granted to the Reporting Person, which are subject to certain vesting conditions.
- [F3]1/4th of the option vested one year from January 29, 2014 and then 1/48th of the option vested monthly thereafter.
Documents
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeother
Related Parties
1- filerCIK 0001603347
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 1:52 PM ET
- Size
- 10.5 KB